THE FUTURE OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE IN THE AFRICAN CONTINENT

Similar documents
HIV and Drug Use Research Fellowship. Programme and Application Webinar

SAVING LIVES: ACHIEVING MORE

April 24, testimony. The AGS is a non-profit organization of nearly 6,000 geriatrics healthcare

Regenerative Orthopedics

Investing in Career Development and Lifelong Learning

Your Joint Pain and Treatment Options

HAEMATOPOIETIC STEM CELL TRANSPLANTATION

RESEARCHER DEVELOPMENT DAYS 2018/2019. Thursday 29 November ICH Wolfson Centre Room A. (Ground floor)

Overcoming joint pain and arthritis

in cooperation with the World Health Organization Hanoi, Vietnam

A Strategic Roadmap for the PICARD Programme in 2020

Elements for a Public Summary

Research For the Future. Len Lichtenfeld, MD, MACP Interim Chief Medical and Scientific Officer

Apostolic Faith Mission of South-Africa Pastors Continuous Development.

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

ARTHRITIS. What happens when Arthritis goes untreated? Often people take arthritis to be a natural part of aging and do not seek medical advice.

THAT S PROVEN FOR THE LONG RUN

A GUIDE FOR PATIENTS KNEE PAIN RELIEF THAT JUST CAN T WAIT

What are stem cells? A stem cell can differentiate into any one of 220 different specialised cells in the body STEM CELLS

RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN

March 8, Written Testimony for FY 2018 Appropriations for the Department of Health and Human Services

SCIENCE BASED PRODUCT

Factors that affect scientific production in Africa: a gender analysis

ESMO 2020 VISION. esmo.org

THE FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE

Autism Speaks Translational Postdoctoral Fellowship Program 2011 Request for Applications

Good Participatory Practice guidelines

TREATMENT OF CARTILAGE LESIONS

Invitation to Tender

COUNCIL. Executive Committee. President Jan Lerut, MD, PhD. President-Elect Michael Charlton, MD. Secretary John R.

Scottish Clinical Leadership Fellowship About the SCLF

Mistakes people make. when seeing a doctor for osteoarthritis knee pain.

The Top Ten Things You Should Know Before Choosing Your Cellular Orthopedic Treatment Specialist

European actions in the field of transplantation & blood transfusion

Most cells in the human body have an assigned purpose. They are liver cells, fat cells, bone cells,

Let s Talk About Clinical Trials: A Discussion Guide for Patients

Living Kidney Donation. Dr. Joseph Keith Melancon

British Association of Stroke Physicians Strategy 2017 to 2020

Sustain and succeed When? Wednesday 25 April 2012 Time? 10am pm Where? Central London

Biomedical Research Strategy Making sure there are effective treatments for deafness, hearing loss and tinnitus

AN INTRODUCTION TO REGENERATIVE MEDICINE

Arthritis Research UK Submission to House of Lords Committee on Science and Technology Inquiry: Regenerative Medicine

HIV Drug Resistance (HIVDR)

WOMEN`S UNIVERSITY IN AFRICA

You can save even more lives. Join the British Bone Marrow Registry

2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines

Kidney Transplantation

PATIENT EDUCATION TOTAL HIP REPLACEMENT

Risk Management Plan Etoricoxib film-coated tablets

KNEE PAIN MANAGEMENT

Technical guidance for Round 9 Global Fund HIV proposals

Midfoot Arthritis - Midfoot Fusion / Arthrodesis Surgery

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH 2017 REQUEST FOR APPLICATION (RFA)

Funding Opportunities for Public Health Research

Shared Decision Making

Is Ginger Effective in Reducing Knee Pain in Adults With Osteoarthritis?

Breaking Down the Problem: Physician Perspectives

ORTHOPEDIC SPECIALISTS STEM CELLS FOR THE TREATMENT OF PAIN DISCOVERING A NEW PATH TO WELLNESS

Date Time Activity Location Key participants Sunday 3 Oct. Workshop on Ageing and Alzheimer s Disease *

HIV/AIDS Research Portfolio Review Working Groups Submits Science Priorities Report to NIH Director

Transforming health through IT

FROM STRENGTH TO STRENGTH

American Society of Nephrology. Raymond C. Harris, MD, FASN President, American Society of Nephrology

REGIONAL COMMITTEE FOR AFRICA AFR/RC51/9 Rev June 2001 Fifty-first session Brazzaville, Congo, 27 August - 1 September 2001

Global crisis Global action. The Cosponsors of UNAIDS. Fact Sheet H V/A DS. Into the fray GLOBAL CRISIS GLOBAL ACTION

Information. about cancer

our aberlour Supporting Children and Families Earlier

2018 AFP INTERNATIONAL COMMITTEE DESCRIPTIONS

Dr Stelios Hadjichristofis. FCS(SA)Orth. / MMed(WITS)Orth. Orthopaedic Surgeon.

Non-operative Treatment of Osteoarthritis. Health Chat June 21 & 22, 2016 Aaron Leininger, MD

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Interprefy your event. Anytime. Anywhere. CLOUD-BASED PLATFORM FOR REMOTE SIMULTANEOUS INTERPRETATION

Florida s Children First, Inc. Strategic Plan

Teaching British Sign Language in schools

CORPORATE RESPONSIBILITY

TETEC the cartilage makers

SEMINAR PROGRAMME Join us on Twitter #brainpower

RESEARCHER DEVELOPMENT DAYS 2016/2017. Wednesday 30 November 2016

JOYFLEX complete OA line

Paediatric and Adolescent HIV Research Grant Programme

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

HEALTH. Infectious Diseases HIV/AIDS

Statement in support of nomination for election to the Cochrane Board Fergus Macbeth MA DM FRCR FRCP MBA

Connecting Affinity Groups to Community Impact Work. United Way of Greenville County Greenville, South Carolina

K Award Career Development Plan

STRATEGIC PLAN

MCF Strategy

Digestive & Metabolic Diseases

The Australian BreastScreen workforce: a snapshot

Breakthrough treatment for pain in Osteoarthritis of the joints. A Patient s Guide

Australian Political Studies Association Survey Report prepared for the APSA Executive

2016 NYC Hep B Coalition Work Plan

Council of Parties Report. Winter 2016/17

A N N U A L R E P O R T

Re-growing the Skeleton: Approaches in Tissue Engineering and Regenerative Medicine

OSTEOCHONDRAL ALLOGRAFT RECONSTRUCTION FOR MASSIVE BONE DEFECT

Strengthening Health Systems and Blood Services

2 WHO 1 Who do you need to involve? a specific condition, service or treatment

FLUOR LIMITED GENDER PAY GAP REPORT 2017

Transcription:

THE FUTURE OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE IN THE AFRICAN CONTINENT DR KEOLEBOGILE MOTAUNG TSHWANE UNIVERSITY OF TECHNOLOGY DEPARTMENT OF BIOMEDICAL SCIENCES TSHWANE SOUTH AFRICA 1

Definition of TE and RM Applications and Benefits Research work OUTLINE Challenges Recommendations to improve gender content and social responsibility of research programmes in Africa that can enhance the effectiveness and sustainability of the development measures needed 2

QUESTIONS? How can one create human spare parts that has been damaged? Why do we have to create spare parts? 3

HOW? TISSUE ENGINEERING AND REGENERATIVE MEDICINE Is as science of design and manufacture of new tissues for the functional restoration of impaired organs and replacement of lost parts due to cancer, diseases and trauma. Creation of human spare parts? 4

WHY? DO WE HAVE TO CREATE HUMAN SPARE PARTS? Shortage of donor tissues and organs Survival rates for major organ transplantations are poor despite their high costs and the body's immune system often rejects donated tissue and organs. Tissue engineering and Regenerative Medicine therefore, has remarkable potential in the medical field to solve these problems 5

APPLICATIONS: HEART FAILURE 6

TYPE 1 DIABETES 7

31 JANUARY 2012- JHB, SOUTH AFRICA 8

MY RESEARCH-TE AND RM OF AC FOR TREATING OA The goal of my research is to ameliorate the dreadful pain and impaired mobility in osteoarthritis by restoration of articular cartilage Articular cartilage is critical to the normal function of human and animal joints; it provides lubrication and load bearing, which makes friction-free locomotion possible. 9

A dynamic change in the cartilage homeostasis precedes the initiation and progression of osteoarthritis, which is an unmet clinical challenge. Challenge to the Orthopedic Surgeons. 10

ARTICULAR CARTILAGE STRUCTURE 11

CURRENT TREATMENT Current treatment of OA focuses mainly on alleviation of pain and loss of joint function. The most common treatments of OA, worldwide, are the following: Allogeneic transplant (is a type of transplant where the recipient is not the same as the donor). Disadvantages are that much of the success of allogeneic transplants depends on finding a good match between the donor and the recipients. 12

Specific medication, such as paracetamol and aspirin, are commonly used, to treat the pain from OA. In more severe cases, non-steroidal anti-inflammatory (NSAID) drugs such as ibuprofen, diclofenac and naproxen may reduce both pain and inflammation. Disadvantages: may also cause gastrointestinal discomfort, cramping, peptic ulcers and diarrhea. 13

WHY TISSUE ENGINEERING AND STEM CELLS (IKS) Medicinal plants and stem cells have the ability to regenerate cartilage and do not have any of the disadvantages mentioned above. Plant based morphogenetic proteins (Compound from medicinal plants) There is currently no treatment, which has restored injured cartilage to its original form with normal functional and structural properties. 14

CHALLENGES Do we have tissue engineering expertise in the African Continent to train (Scientist esp. females) Answer: Yes/No Can we performed tissue engineering and regenerative medicine research in the African Continent? Answer: Yes/No (Dr Chris Barnard and Dr Mia ) Do we have women in this field in South Africa? 15

CHALLENGES At the time of tenure. (biological clock), where intense workload demands of establishing an independent research program and fostering a young family exactly overlap, result in higher attrition rates in women vs. men in academic careers. A gender equality issue since lack of appropriate mentoring is also linked to higher attrition rates in women vs. men in academic positions. A male dominated culture in higher education and research council does not support the development and retention of women researchers 16

Most research grant for young researchers have age limit to the disadvantage of women researchers who normally are late bloomers. 17

RECOMMENDATION : TO IMPROVE GENDER CONTENT 1. Implement flexible family care spending This awards enable grantees to use award funds for family-related expenses, such as childcare and eldercare Would allow individuals to travel to meetings, conferences, and workshops that may be important for early career advancement. Grant making organizations (UNESCO, MRC and NRFetc) and institutions must set up women positive award programs 18

FOCUS ON PSYCHOLOGICAL AND CULTURAL CHANGE Recruit gender-balanced external review committees and speaker selection committees (Proposals) Organizations that fund research and convene meetings should assemble gender-balanced review and speaker selection committees. 19

FOCUS ON EDUCATION AS A TOOL Institutions, grant makers, and scientists must commit to education as a tool to make progress towards gender equality, for example, through hosting and providing training seminars, workshops, and discussions, and share these resources with the scientific and lay community as widely as possible. Institutional transformation in the culture of the universities and research organization to support women researchers 20

OPPORTUNITIES FOR ADVANCING AWARENESS AND UNDERSTANDING OF GENDER ISSUES Having more women in senior administrative positions and enabling them to serve as appropriate mentors and role models to their younger colleagues could help avoid the traps in academic career development Recommendation suggests that funders, journals, and institutions should partner with existing organizations to develop and expand existing, searchable databases of women in science, engineering, and medicine. 21

These resources will make it easier for search committees, conference organizers, institutions, and others to easily identify women scientists for positions and activities such as speaking opportunities, participation in review committees, serving on advisory boards, and others. 22

23

THANK YOU!!!!!!! 24